Ozempic tablets are now available; investigational ALS treatment gains FDA Fast Track status; positive results for aficamten ...

HealthDay News — As an investigation continues into a hantavirus outbreak that killed three passengers and sickened five on an ocean liner, the World Health Organization (WHO) says the odds of broader ...

A major amendment has prompted the FDA to extend its review of subcutaneous lecanemab as a starting dose for early Alzheimer disease.

Relative vaccine efficacy was 26.6 percent, which met the criteria for noninferiority, superiority, higher-level superiority.

Based on the current evidence, there is no consistent association between vaccines and serious or long-term health outcomes.

It’s also not clear that HHS has the regulatory authority to enforce its threat without going through a formal rulemaking process, lawyers and dietitians say.

Botulinum toxin may slightly reduce monthly migraine days but has higher discontinuation rates due to adverse events.

Bladder-intact disease-free survival was 60% 2 years posttreatment with pembrolizumab combined with gemcitabine-based chemoradiation.

Glucagon-like peptide-1 (GLP-1) receptor agonists may be a potential novel treatment for alcohol use disorder, according to a ...

This marks a shift from years of aggressive regulation against flavored vapes after the FDA rejected marketing approvals for more than 1 million flavored products.

Treatments for COVID-19, gout, nicotine dependence, severe hypertriglyceridemia, and thyroid eye disease are under review.

Researchers found that both products alone and in combination were safe, with no related serious adverse events in mothers or infants. HealthDay News — Maternal respiratory syncytial virus (RSV) ...